Jashvik Capital Fuels Marg ERP's Digital Ascent in Healthcare Tech
August 1, 2025, 9:32 pm
Location: India, Maharashtra, Mumbai
Employees: 1001-5000
Founded date: 2015
Total raised: $2.24B
Location: India, Maharashtra, Navi Mumbai
Employees: 1001-5000
Founded date: 1996
Jashvik Capital injects over INR 400 Cr into Marg ERP. This fuels digital transformation, accelerating product innovation and global market expansion. The investment targets India's dominant ERP provider in healthcare and pharma, serving 500,000+ global subscribers. This strategic private equity commitment aims to elevate Marg ERP into a global healthcare SaaS leader, supporting founder-led growth and enhancing patient access through technology.
Jashvik Capital, a prominent private equity firm, has made a significant investment. Over INR 400 crore ($45.7 million) flowed into Marg ERP. This move marks a pivotal moment for both entities. It signals robust confidence in India's burgeoning healthcare technology sector.
Marg ERP stands as a leading Indian software provider. It specializes in ERP and inventory management solutions. Small and medium enterprises (SMEs) are its core focus. The company boasts extensive reach. It serves over 500,000 subscribers. These include businesses across healthcare, FMCG, and retail sectors. Marg ERP operates in India and 32 other countries.
The investment aims to accelerate Marg ERP's strategic objectives. Product innovation is a key focus. Customer experience enhancement is another priority. Expansion across domestic and international markets will intensify. This funding empowers Marg ERP's ambitious growth plans.
Marg ERP holds a strong position in the pharmaceutical value chain. Nearly half of India's pharmaceutical distribution and retail businesses utilize its software. This dominance highlights its critical role. It streamlines operations for a vast network of drug manufacturers, distributors, and retailers. Marg ERP’s ECOD platform is vital. It enables pharmaceutical companies. Its AI-enabled ordering and payment solutions also assist retailers and distributors.
The company's growth trajectory is impressive. It reports an annual growth rate exceeding 25 percent. This expansion largely stems from word-of-mouth referrals. A vast network supports this growth. Over 850 channel partners operate across more than 650 cities. This robust ecosystem fosters sustained organic growth.
Jashvik Capital's investment will fuel both organic and inorganic growth strategies. Marg ERP seeks to deepen its footprint globally. Its recently launched cloud-based accounting and ERP product, Marg Book, is crucial here. This product facilitates broader international reach. The long-term vision positions Marg ERP as a global healthcare SaaS leader. This strategy involves empowering various industry participants. Retailers, distributors, manufacturers, hospitals, and physicians benefit from Marg's solutions. The ultimate goal is enhancing patient access to affordable healthcare. It also aims to improve patient outcomes.
Jashvik Capital’s investment aligns with its core strategy. The firm supports founder-led businesses. These businesses must address large-scale, real-world challenges. This is the fourth investment from Jashvik Capital Fund I. The firm focuses on healthcare, consumer, and technology sectors. Prior investments include Futura Surgicare Pvt. Ltd., a medical products seller. Jashvik also acquired a majority stake in insecticide maker Midas Hygiene earlier this year. Its maiden fund targets $350 million. The government-backed Self-Reliant Fund (SRI Fund) is a limited partner.
The relationship between Jashvik Capital and Marg ERP's founders is long-standing. Jashvik Capital leadership expressed consistent admiration. They noted the founders' strategic foresight. Their passion for leveraging technology to empower entrepreneurs is evident. This has built a strong, resilient business. The company is well-positioned for future expansion. This aligns with India's healthcare shift. The industry moves towards value and outcomes-based models.
A recent corporate maneuver adds context to this investment. Marg ERP's founders recently repurchased a 49 percent stake. This stake was previously held by API Holdings. API Holdings is the parent company of PharmEasy and Thyrocare. This buyback demonstrates the founders' commitment. It consolidates their control over the company's strategic direction. This move precedes Jashvik Capital’s new investment. It sets the stage for fresh capital injection and strategic partnership.
The investment signifies more than financial backing. It represents a strategic alliance. Jashvik Capital brings deep expertise. This spans healthcare, pharma, and health tech sectors. This expertise will guide Marg ERP's journey. The collaboration aims to build world-class healthcare technology infrastructure.
The deal underscores a growing trend. Private equity firms increasingly target India's digital economy. Technology solutions for traditional sectors, like healthcare and pharmaceuticals, are highly attractive. Marg ERP’s proven track record and extensive network make it a compelling target. Its specialization in a critical sector ensures continued relevance and growth. The digital transformation of India's supply chain is ongoing. Marg ERP is at its forefront.
This investment will drive significant advancements. It will enhance Marg ERP’s product portfolio. New features and functionalities will emerge. User experience will improve. The company can invest in cutting-edge technologies. This includes further developing its AI capabilities. It will also bolster its cloud infrastructure. Such developments are crucial for global competitiveness.
The pharmaceutical sector particularly benefits. Improved ERP solutions streamline inventory management. They enhance supply chain visibility. They optimize distribution processes. This leads to greater efficiency. It reduces operational costs. Ultimately, it ensures timely access to essential medicines. This directly impacts patient welfare.
In summary, Jashvik Capital’s investment is transformative. It empowers Marg ERP. It accelerates its digital mission. It targets global leadership in healthcare SaaS. This strategic partnership fosters innovation. It enhances market reach. It contributes significantly to India's digital healthcare infrastructure. The future looks promising for Marg ERP and its extensive network.
Jashvik Capital, a prominent private equity firm, has made a significant investment. Over INR 400 crore ($45.7 million) flowed into Marg ERP. This move marks a pivotal moment for both entities. It signals robust confidence in India's burgeoning healthcare technology sector.
Marg ERP stands as a leading Indian software provider. It specializes in ERP and inventory management solutions. Small and medium enterprises (SMEs) are its core focus. The company boasts extensive reach. It serves over 500,000 subscribers. These include businesses across healthcare, FMCG, and retail sectors. Marg ERP operates in India and 32 other countries.
The investment aims to accelerate Marg ERP's strategic objectives. Product innovation is a key focus. Customer experience enhancement is another priority. Expansion across domestic and international markets will intensify. This funding empowers Marg ERP's ambitious growth plans.
Marg ERP holds a strong position in the pharmaceutical value chain. Nearly half of India's pharmaceutical distribution and retail businesses utilize its software. This dominance highlights its critical role. It streamlines operations for a vast network of drug manufacturers, distributors, and retailers. Marg ERP’s ECOD platform is vital. It enables pharmaceutical companies. Its AI-enabled ordering and payment solutions also assist retailers and distributors.
The company's growth trajectory is impressive. It reports an annual growth rate exceeding 25 percent. This expansion largely stems from word-of-mouth referrals. A vast network supports this growth. Over 850 channel partners operate across more than 650 cities. This robust ecosystem fosters sustained organic growth.
Jashvik Capital's investment will fuel both organic and inorganic growth strategies. Marg ERP seeks to deepen its footprint globally. Its recently launched cloud-based accounting and ERP product, Marg Book, is crucial here. This product facilitates broader international reach. The long-term vision positions Marg ERP as a global healthcare SaaS leader. This strategy involves empowering various industry participants. Retailers, distributors, manufacturers, hospitals, and physicians benefit from Marg's solutions. The ultimate goal is enhancing patient access to affordable healthcare. It also aims to improve patient outcomes.
Jashvik Capital’s investment aligns with its core strategy. The firm supports founder-led businesses. These businesses must address large-scale, real-world challenges. This is the fourth investment from Jashvik Capital Fund I. The firm focuses on healthcare, consumer, and technology sectors. Prior investments include Futura Surgicare Pvt. Ltd., a medical products seller. Jashvik also acquired a majority stake in insecticide maker Midas Hygiene earlier this year. Its maiden fund targets $350 million. The government-backed Self-Reliant Fund (SRI Fund) is a limited partner.
The relationship between Jashvik Capital and Marg ERP's founders is long-standing. Jashvik Capital leadership expressed consistent admiration. They noted the founders' strategic foresight. Their passion for leveraging technology to empower entrepreneurs is evident. This has built a strong, resilient business. The company is well-positioned for future expansion. This aligns with India's healthcare shift. The industry moves towards value and outcomes-based models.
A recent corporate maneuver adds context to this investment. Marg ERP's founders recently repurchased a 49 percent stake. This stake was previously held by API Holdings. API Holdings is the parent company of PharmEasy and Thyrocare. This buyback demonstrates the founders' commitment. It consolidates their control over the company's strategic direction. This move precedes Jashvik Capital’s new investment. It sets the stage for fresh capital injection and strategic partnership.
The investment signifies more than financial backing. It represents a strategic alliance. Jashvik Capital brings deep expertise. This spans healthcare, pharma, and health tech sectors. This expertise will guide Marg ERP's journey. The collaboration aims to build world-class healthcare technology infrastructure.
The deal underscores a growing trend. Private equity firms increasingly target India's digital economy. Technology solutions for traditional sectors, like healthcare and pharmaceuticals, are highly attractive. Marg ERP’s proven track record and extensive network make it a compelling target. Its specialization in a critical sector ensures continued relevance and growth. The digital transformation of India's supply chain is ongoing. Marg ERP is at its forefront.
This investment will drive significant advancements. It will enhance Marg ERP’s product portfolio. New features and functionalities will emerge. User experience will improve. The company can invest in cutting-edge technologies. This includes further developing its AI capabilities. It will also bolster its cloud infrastructure. Such developments are crucial for global competitiveness.
The pharmaceutical sector particularly benefits. Improved ERP solutions streamline inventory management. They enhance supply chain visibility. They optimize distribution processes. This leads to greater efficiency. It reduces operational costs. Ultimately, it ensures timely access to essential medicines. This directly impacts patient welfare.
In summary, Jashvik Capital’s investment is transformative. It empowers Marg ERP. It accelerates its digital mission. It targets global leadership in healthcare SaaS. This strategic partnership fosters innovation. It enhances market reach. It contributes significantly to India's digital healthcare infrastructure. The future looks promising for Marg ERP and its extensive network.